相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid
Makoto Tahara et al.
EUROPEAN JOURNAL OF CANCER (2017)
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2017)
Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
Naomi Kiyota et al.
THYROID (2017)
Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
Yasuhiro Ito et al.
THYROID (2017)
Association of Baseline Neutrophil-to-Lymphocyte Ratio with Clinicopathological Characteristics of Papillary Thyroid Carcinoma
Dimitrios K. Manatakis et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2017)
The prognostic value of neutrophil-lymphocyte ratio is superior to derived neutrophil-lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up
Hailong Jin et al.
ONCOTARGETS AND THERAPY (2017)
Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
Guopei Luo et al.
ONCOLOGY LETTERS (2017)
Lenvatinib for Anaplastic Thyroid Cancer
Makoto Tahara et al.
FRONTIERS IN ONCOLOGY (2017)
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
Martin Schlumberger et al.
CLINICAL CANCER RESEARCH (2016)
Temporary changes in neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios, and mean platelet volume reflecting the inflammatory process after radioiodine therapy
Yusuf Demir et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
The immune network in thyroid cancer
Maria Rosaria Galdiero et al.
ONCOIMMUNOLOGY (2016)
Association between neutrophil-to-lymphocyte ratio and differentiated thyroid cancer: a meta-analysis
Ji-Feng Liu et al.
SCIENTIFIC REPORTS (2016)
A Phase 2 Trial of Lenvatinib (E7080) in Advanced, Progressive, Radioiodine-Refractory, Differentiated Thyroid Cancer: A Clinical Outcomes and Biomarker Assessment
Maria E. Cabanillas et al.
CANCER (2015)
Subgroup analysis of Japanese patients in a phase 3 study of lenvatinib in radioiodine-refractory differentiated thyroid cancer
Naomi Kiyota et al.
CANCER SCIENCE (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer
Jin-Seong Cho et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2015)
Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis
Chen-Tian Shen et al.
ENDOCRINE-RELATED CANCER (2014)
Long-term results of radiotherapy in anaplastic thyroid cancer
Anne-Katrin Dumke et al.
RADIATION ONCOLOGY (2014)
Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models
Kiyoshi Okamoto et al.
CANCER LETTERS (2013)
Cabozantinib in Progressive Medullary Thyroid Cancer
Rossella Elisei et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC Research Consortium of Japan Cohort Study of 677 Patients
Iwao Sugitani et al.
WORLD JOURNAL OF SURGERY (2012)
Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions
Furio Pacini et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2012)
Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992-2006
Briseis Aschebrook-Kilfoy et al.
THYROID (2011)
Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment
Govardhanan Nagaiah et al.
JOURNAL OF ONCOLOGY (2011)
A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080
Ron J. Keizer et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase
Junji Matsui et al.
CLINICAL CANCER RESEARCH (2008)
E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition
Junji Matsui et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
分享论文
